Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Blood Cancer
  •  Neoadjuvant Therapy
  •  General Oncology
  •  Leukemia
  •  Sarcomas
  •  Melanoma/Skin Cancer
  •  Breast Cancer
  •  Gastrointestinal Cancer

Abstract

Citation: Clin Oncol. 2023;8(1):2014.DOI: 10.25107/2474-1663.2014

Bowen's Disease and Eccrine Porocarcinoma Developed after Herniorrhaphy: A Case Report and Literatures Review

Chea K, Huang Q, Chena B and Hua X

Department of Dermatology, Shenzhen Hospital, Peking University, China
Shantou University Medical College, China

*Correspondance to: Xiaoping Hu 

 PDF  Full Text Case Report | Open Access

Abstract:

Eccrine Porocarcinoma is a rare cutaneous tumor with high invasiveness and risk of metastasis. It usually presents clinically as red nodule, plaque, ulcerated lesion or neoplasm. It is hard to diagnose without histopathology. Surgery is the mainstream treatment. We are reporting a case of eccrine porocarcinoma arising in right mons pubis, where had Bowen’s disease previous after herniorrhaphy, as well as reviewing literatures about eccrine porocarcinoma.

Keywords:

Eccrine porocarcinoma; Bowen’s disease; Scar; Herniorrhaphy; Trauma

Cite the Article:

Chea K, Huang Q, Chena B, Hua X. Bowen's Disease and Eccrine Porocarcinoma Developed after Herniorrhaphy: A Case Report and Literatures Review. Clin Oncol. 2023;8:2014..

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

The Protective Effects of Hepatopoietin Cn (HPPCn) on Acute Liver Injury
 Abstract  PDF  Full Text
A Randomised Controlled Trial to Determine the Effect of Triptorelin on Reduction of Prostate Volume PreRadiotherapy Compared with Standard Therapy (Goserelin)
 Abstract  PDF  Full Text
View More...